These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: High-affinity [3H]6-nitroquipazine binding sites in rat brain.
    Author: Hashimoto K, Goromaru T.
    Journal: Eur J Pharmacol; 1990 May 16; 180(2-3):273-81. PubMed ID: 1694774.
    Abstract:
    6-Nitroquipazine is a very potent and selective inhibitor of neuronal 5-hydroxytryptamine (5-HT; serotonin) uptake. We have characterized the specific binding of [3H]6-nitroquipazine to rat brain membranes at 22 degrees C. The present results indicate the presence of a single saturable high-affinity binding component for [3H]6-nitroquipazine. Scatchard analysis revealed an apparent equilibrium dissociation constant (Kd) of 93.0 +/- 2.23 pM, and a maximal number of binding sites (Bmax) of 831.7 +/- 18.7 fmol/mg protein (mean +/- S.D., n = 4). The kinetically derived dissociation constant was 74.5 pM. [3H]6-Nitroquipazine binding was inhibited selectively by 5-HT uptake inhibitors, and a good correlation was demonstrated between the potency of various drugs to inhibit [3H]6-nitroquipazine binding and [3H]5-HT uptake. The highest densities of [3H]6-nitroquipazine binding were obtained in the hypothalamus and midbrain, intermediate binding was observed in the striatum, hippocampus, medulla oblongata and cortex, and the lowest binding was observed in the cerebellum. Lesioning of 5-HT neurons with p-chloroamphetamine resulted in a 72% reduction in [3H]6-nitroquipazine binding compared to controls. These results indicate that the binding site specifically labelled by [3H]6-nitroquipazine is associated with the neuronal 5-HT transporter complex. [3H]6-Nitroquipazine is an excellent radioligand for the study of the 5-HT uptake system.
    [Abstract] [Full Text] [Related] [New Search]